Author:
Dalwadi Dhwanil A.,Ozuna Luis,Harvey Brian H.,Viljoen Michelle,Schetz John A.
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference295 articles.
1. Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases;Allavena;Antivir Ther,2006
2. Efavirenz: what is known about the cellular mechanisms responsible for its adverse effects;Apostolova;Eur J Pharmacol,2017
3. Involvement of Nitric Oxide in the Mitochondrial Action of Efavirenz: A Differential Effect on Neurons and Glial Cells
4. Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals
5. Arenas-Pinto A Grund B Sharma S Martinez E Cummins N Fox J Klingman K Sedlacek D Collins S Flynn P (2016) Increased risk of suicidal behaviour with use of efavirenz: results from START trial, in 21st World AIDS Conferences; July 18–22 2016; Durban, South Africa.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献